Altered microRNA regulation in Huntington's disease models

Huntington's disease (HD) is a genetic neurodegenerative disease caused by abnormal CAG expansion. MicroRNAs (miRNAs) are short RNA molecules regulating gene expression, and are implicated in a variety of diseases including HD. However, the profiles and regulation of miRNAs in HD are not fully understood. Here, we analyzed the miRNA expression and miRNA regulators in two transgenic models of HD, YAC128 and R6/2 mice, and in a 3-nitropropionic acid (3NP)-induced striatal degeneration rat model. After characterizing the phenotypes by behavioral tests and histological analyses, we profiled striatal miRNAs using a miRNA microarray and we measured the key molecules involved in miRNA biogenesis and function. YAC128 mice showed upregulation-dominant miRNA expressions at 5 months and downregulation-dominant expressions at 12 months. Concomitantly, the expressions of Drosha-DGCR8, Exportin-5, and Dcp1 were increased at 5months, and the expression of Dicer was decreased at 12 months. In 10-week-old R6/2 mice, downregulation was dominant in the miRNA expressions and the level of Drosha decreased concomitantly. Nine miRNAs (miR-22, miR-29c, miR-128, miR-132, miR-138, miR-218, miR-222, miR-344, and miR-674*) were commonly down-regulated in both the 12-month-old YAC128 and 10-week-old R6/2 mice. Meanwhile, 3NP rats showed dynamic changes in the miRNA profiles during disease development and a few miRNAs with altered expression. Our results show that transgenic HD mice have abnormal miRNA biogenesis. This information should aid in future studies on therapeutic application of miRNAs in HD.

[1]  Andrea Crotti,et al.  Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes , 2003, Nature Genetics.

[2]  Lu Jiang,et al.  MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. , 2009, Cancer letters.

[3]  M. MacDonald,et al.  Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease , 2007, The Journal of Neuroscience.

[4]  J. Roh,et al.  Slowed progression in models of huntington disease by adipose stem cell transplantation , 2009, Annals of neurology.

[5]  D. Blum,et al.  3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease , 2005, Journal of neurochemistry.

[6]  G. Tsujimoto,et al.  Sustained activation of ERK1/2 by NGF induces microRNA‐221 and 222 in PC12 cells , 2009, The FEBS journal.

[7]  M. Hayden,et al.  Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. , 2005, Human molecular genetics.

[8]  Jessica Treisman,et al.  The Conserved microRNA MiR-8 Tunes Atrophin Levels to Prevent Neurodegeneration in Drosophila , 2007, Cell.

[9]  P. Greengard,et al.  Cerebellar neurodegeneration in the absence of microRNAs , 2007, The Journal of experimental medicine.

[10]  Hong Lu,et al.  Reduced microRNA‐218 expression is associated with high nuclear factor kappa B activation in gastric cancer , 2009, Cancer.

[11]  D. Ehrnhoefer,et al.  Mouse models of Huntington disease: variations on a theme , 2009, Disease Models & Mechanisms.

[12]  V. Kim,et al.  Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.

[13]  S. Snyder,et al.  p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.

[14]  M. Peschanski,et al.  Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration , 2002, The Journal of Neuroscience.

[15]  Jiandie D. Lin,et al.  Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators , 2006, Cell.

[16]  D. Busija,et al.  Opening of Mitochondrial ATP-Sensitive Potassium Channels Is a Trigger of 3-Nitropropionic Acid–Induced Tolerance to Transient Focal Cerebral Ischemia in Rats , 2003, Stroke.

[17]  Yi Xing,et al.  The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease , 2008, The Journal of Neuroscience.

[18]  T. Kwok,et al.  The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. , 2009, Carcinogenesis.

[19]  D. Valle,et al.  MicroRNA (miRNA) Transcriptome of Mouse Retina and Identification of a Sensory Organ-specific miRNA Cluster* , 2007, Journal of Biological Chemistry.

[20]  E. Sontheimer,et al.  Distinct Roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA Silencing Pathways , 2004, Cell.

[21]  U. Kutay,et al.  Nuclear Export of MicroRNA Precursors , 2004, Science.

[22]  B. Hyman,et al.  Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  Jin-Wu Nam,et al.  miR-29 miRNAs activate p53 by targeting p85α and CDC42 , 2009, Nature Structural &Molecular Biology.

[24]  R. Shiekhattar,et al.  Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies , 2008, Proceedings of the National Academy of Sciences.

[25]  G. Bates,et al.  Huntingtin and the molecular pathogenesis of Huntington's disease , 2004, EMBO reports.

[26]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[27]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[28]  S. Krajewski,et al.  Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration Induced In Vivo by 3-Nitropropionate: Implications for Huntington's Disease , 2003, The Journal of Neuroscience.

[29]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[30]  H. Soreq,et al.  MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. , 2009, Immunity.

[31]  P. Calabresi,et al.  NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: Implications for Huntington's disease , 2008, Neuroscience Letters.

[32]  Christina Thaller,et al.  miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis , 2008, Nature Neuroscience.

[33]  Elena Cattaneo,et al.  A microRNA-based gene dysregulation pathway in Huntington's disease , 2008, Neurobiology of Disease.

[34]  R. Barker,et al.  Abnormalities of Neurogenesis in the R6/2 Mouse Model of Huntington's Disease Are Attributable to the In Vivo Microenvironment , 2005, The Journal of Neuroscience.

[35]  Michael T. McManus,et al.  Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration , 2008, Proceedings of the National Academy of Sciences.

[36]  Erika Pastrana,et al.  miR-124 regulates adult neurogenesis in the SVZ stem cell niche , 2009, Nature Neuroscience.

[37]  A. Schier,et al.  Members of the miRNA-200 Family Regulate Olfactory Neurogenesis , 2008, Neuron.

[38]  E. Simpson,et al.  Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. , 2003, Human molecular genetics.

[39]  K. Chu,et al.  Atorvastatin attenuates mitochondrial toxin‐induced striatal degeneration, with decreasing iNOS/c‐Jun levels and activating ERK/Akt pathways , 2008, Journal of neurochemistry.

[40]  D. Rubinsztein,et al.  Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.

[41]  D. Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[42]  Stephen W. Wilson,et al.  MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system , 2007, Genome Biology.

[43]  O. Maes,et al.  Murine microRNAs implicated in liver functions and aging process , 2008, Mechanisms of Ageing and Development.

[44]  P. Anderson,et al.  Mammalian stress granules and processing bodies. , 2007, Methods in enzymology.

[45]  Wei Liu,et al.  MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a , 2008, Journal of Molecular Medicine.